Komipharm International Co. Ltd Cash Flow Reinvestment Rate
Komipharm International Co. Ltd cash flow reinvestment rate. Komipharm International Co. Ltd (041960) has a Cash Flow Reinvestment Rate of 5.10x as of December 2025, reinvesting ₩4.83 Billion (capex ₩1.85 Billion plus investments ₩2.98 Billion) from operating cash flow of ₩946.94 Million. See 041960 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Komipharm International Co. Ltd (2013–2024)
Cash flow reinvestment rate of Komipharm International Co. Ltd from 2013 to 2024. Historical reinvestment intensity for Komipharm International Co. Ltd across 6 annual periods. Explore how well can Komipharm International Co. Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Komipharm International Co. Ltd Cash Flow Reinvestment Rate by Year (2013–2024)
Komipharm International Co. Ltd cash flow reinvestment rate by year from 2013 to 2024. Year-by-year capital reinvestment analysis for Komipharm International Co. Ltd. For the full cash flow conversion analysis, see cash flow conversion of Komipharm International Co. Ltd.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.67x | ₩5.96 Billion | ₩8.85 Billion | ₩3.98 Billion | ▼ -99.1% |
| 2020 | 76.26x | ₩1.92 Billion | ₩25.20 Million | ₩1.66 Billion | ▲ +1149.9% |
| 2019 | 6.10x | ₩5.80 Billion | ₩950.79 Million | ₩5.74 Billion | ▼ -57.5% |
| 2017 | 14.35x | ₩3.38 Billion | ₩235.64 Million | ₩2.68 Billion | ▲ +5.5% |
| 2016 | 13.60x | ₩16.43 Billion | ₩1.21 Billion | ₩12.24 Billion | ▲ +114.6% |
| 2013 | 6.34x | ₩24.93 Billion | ₩3.93 Billion | ₩24.93 Billion | — |